These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Expanding the 43C9 class of catalytic antibodies using a chain-shuffling approach. Miller GP; Posner BA; Benkovic SJ Bioorg Med Chem; 1997 Mar; 5(3):581-90. PubMed ID: 9113336 [TBL] [Abstract][Full Text] [Related]
67. From molecular diversity to catalysis: lessons from the immune system. Schultz PG; Lerner RA Science; 1995 Sep; 269(5232):1835-42. PubMed ID: 7569920 [TBL] [Abstract][Full Text] [Related]
69. The enzymic nature of antibody catalysis: development of multistep kinetic processing. Benkovic SJ; Adams JA; Borders CL; Janda KD; Lerner RA Science; 1990 Nov; 250(4984):1135-9. PubMed ID: 2251500 [TBL] [Abstract][Full Text] [Related]
70. Conformational isomerism can limit antibody catalysis. Debler EW; Müller R; Hilvert D; Wilson IA J Biol Chem; 2008 Jun; 283(24):16554-60. PubMed ID: 18417480 [TBL] [Abstract][Full Text] [Related]
71. Analysis of ground-state and transition-state effects in enzyme catalysis. Menger FM Biochemistry; 1992 Jun; 31(23):5368-73. PubMed ID: 1606161 [TBL] [Abstract][Full Text] [Related]
72. A rat monoclonal antibody that catalyses the hydrolysis of a nitrophenyl-beta-lactam. Ostler EL; Dean CJ; Barber N; Valeri M; James S; Resmini M; Boucher G; Romanov N; Brocklehurst K; Gallacher G Biochem Biophys Res Commun; 2002 Nov; 299(2):273-6. PubMed ID: 12437982 [TBL] [Abstract][Full Text] [Related]
73. Catalyst design for reactions with multiple transition states. DeSilva BS; Wilson GS; Schowen RL Chem Immunol; 2000; 77():33-57. PubMed ID: 11706705 [No Abstract] [Full Text] [Related]
74. On the generation of catalytic antibodies by transition state analogues. Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J; Warshel A Chembiochem; 2003 Apr; 4(4):277-85. PubMed ID: 12672107 [TBL] [Abstract][Full Text] [Related]
76. The therapeutic potential for catalytic antibodies: from a concept to a promise. Jones LH; Wentworth P Mini Rev Med Chem; 2001 Jul; 1(2):125-32. PubMed ID: 12369978 [TBL] [Abstract][Full Text] [Related]
78. Transition state stabilization and enzymic rate acceleration. Polgár L Acta Biochim Biophys Hung; 1989; 24(1-2):25-32. PubMed ID: 2514538 [No Abstract] [Full Text] [Related]
79. Chemical equilibrium at an antibody binding site: catalytic efficiency defined by a Haldane relationship. Janjić N; Tramontano A Biochemistry; 1990 Sep; 29(37):8867-72. PubMed ID: 2271563 [TBL] [Abstract][Full Text] [Related]
80. An active immunization approach to generate protective catalytic antibodies. Wang J; Han Y; Wilkinson MF Biochem J; 2001 Nov; 360(Pt 1):151-7. PubMed ID: 11696002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]